90
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Properties of artificial cationic oligodiaminosaccharides and oligopeptides that bind to A-type oligonucleotide duplexes

, , & ORCID Icon
Pages 619-636 | Received 09 Nov 2022, Accepted 08 Feb 2023, Published online: 27 Feb 2023
 

Abstract

A critical strategy to improve the properties of oligonucleotide therapeutics is using cationic molecules as carriers. We developed artificial cationic molecules that bind to A-type oligonucleotide duplexes, such as siRNAs, in a stoichiometric ratio. In this study, we investigated the properties of oligo 2,6-diamino-D-galactoses (ODAGals) and L-2,4-diaminobutanoic acid oligomers (Dabs) and revealed their thermal and biological stabilization effects on A-type duplexes and their chemical stability. As a result, ODAGal and Dab with the same number of amino groups had the commensurate ability for the biological stabilization effect, whereas Dab enhanced the thermal stability of A-type duplexes more effectively than ODAGal.

Acknowledgments

We thank Dr. Yayoi Yoshimura (Tokyo University of Science) for measuring the mass spectra. We thank Enago (www.enago.jp) for the English-language review.

Disclosure statement

The authors declare no conflicts of interest.

Author contributions

All authors conceptualized the research, T. S. conducted the experiments and wrote the manuscript, and K. S., R. I. H., and T. W. revised the manuscript. All authors analyzed data and approved the final version of the manuscript.

Data availability statement

The authors confirm that the data supporting the findings of this study are available in the article and/or its supplementary materials.

Additional information

Funding

This research was supported by the Science and Technology Platform Program for Advanced Biological Medicine (22am0401006s0104) from the Japan Agency for Medical Research and Development and JSPS KAKENHI (19K06993).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.